Ileitis / Porcine Proliferative Enteropathy (Lawsonia)

Ileitis, formally known as porcine proliferative enteropathy, is a significant infectious disease of swine caused by the obligate intracellular bacterium Lawsonia intracellularis. This condition manifests primarily as inflammation and thickening of the intestinal wall, particularly affecting the ileum and terminal small intestine, leading to reduced nutrient absorption, diarrhea, poor growth performance, and in severe acute forms, potentially fatal hemorrhage. The disease represents one of the most economically important enteric conditions in modern swine production worldwide, affecting operations across all production systems from small farms to large commercial enterprises.

The condition affects swine populations globally, with seroprevalence studies indicating that Lawsonia intracellularis infection is nearly ubiquitous in pig populations, with 60 to 100 percent of herds testing positive depending on the region and testing methodology used. Clinical disease occurs in a smaller proportion of infected animals, but the subclinical form causing growth reduction without obvious illness is extremely common and contributes substantially to economic losses. The disease primarily affects growing pigs between 6 and 20 weeks of age, though the acute hemorrhagic form more commonly strikes older animals including young breeding stock and recently introduced gilts.

Economic impact of ileitis on swine operations is substantial and encompasses both obvious clinical losses and hidden subclinical effects. The acute hemorrhagic form causes mortality that can reach 50 percent in affected groups without treatment, representing direct loss of valuable animals near market weight or breeding stock investment. The chronic and subclinical forms reduce average daily gain by 6 to 20 percent and impair feed conversion efficiency, extending time to market and increasing feed costs per pound of gain. Industry estimates suggest that ileitis costs the global swine industry several hundred million dollars annually through combined mortality, reduced performance, treatment expenses, and carcass condemnations.

Treatability of ileitis is generally good when the condition is recognized early and appropriate antimicrobial therapy is initiated, though the acute hemorrhagic form carries guarded prognosis due to rapid disease progression. Prevention through vaccination has become an important management tool, with commercial vaccines demonstrating efficacy in reducing clinical disease and improving growth performance in endemic herds. Understanding of this condition and its various clinical presentations enables producers and veterinarians to implement effective control programs combining vaccination, strategic antimicrobial use, and management practices that reduce transmission and disease impact on swine operations.

Ileitis is caused by Lawsonia intracellularis, a gram-negative, curved, obligate intracellular bacterium that specifically infects and replicates within the cytoplasm of intestinal epithelial cells. The organism was first isolated in the early 1990s following decades of recognizing the disease based on characteristic pathological lesions. As an obligate intracellular pathogen, Lawsonia cannot replicate outside living host cells, which complicates laboratory cultivation and historically limited diagnostic capabilities. The bacterium enters intestinal epithelial cells, particularly those in the crypts of the ileum, where it multiplies and causes the characteristic proliferative changes in the intestinal mucosa that give the disease its name.

While no specific breed or genetic predisposition to ileitis has been conclusively demonstrated, individual variation in susceptibility exists and may have genetic components. Immune response characteristics that vary between animals influence whether infection results in clinical disease or is controlled without obvious illness. Some genetic lines may demonstrate different susceptibility patterns, though this has not been systematically characterized to the degree seen with some other swine diseases. The primary determinants of clinical disease expression appear to be infectious dose, immune status, and concurrent stressors rather than genetic factors per se.

Environmental and management factors significantly influence transmission of Lawsonia intracellularis and expression of clinical disease. The organism is shed in feces of infected pigs and survives in the environment for one to two weeks under favorable conditions, with cooler temperatures extending survival. Continuous flow production systems that maintain constant pig populations without complete depopulation and sanitation allow bacterial buildup and ongoing transmission between age groups. Inadequate cleaning and disinfection between groups leaves residual contamination for incoming naive pigs. High stocking density increases contact between animals and environmental bacterial loads. Mixing of pigs from different sources brings together animals with varying infection and immune status, facilitating transmission.

Risk factors for clinical ileitis include age, immune status, concurrent disease, and management stressors. Growing pigs between 6 and 20 weeks of age are most susceptible to the chronic proliferative form, corresponding to the period of waning maternal immunity and high growth demands. The acute hemorrhagic form more commonly affects older animals from 4 to 12 months of age, including finishing pigs approaching market weight and young breeding stock. Immunosuppressive conditions including porcine circovirus type 2 infection increase susceptibility and may worsen disease severity. Transportation, facility changes, feed transitions, and social stress from mixing predispose to clinical disease in infected animals. Concurrent enteric infections with rotavirus, transmissible gastroenteritis virus, or bacterial pathogens may exacerbate disease presentation.

The pathophysiology of ileitis involves bacterial invasion of intestinal crypt epithelial cells leading to abnormal proliferation and loss of normal function. After oral ingestion of contaminated fecal material, Lawsonia intracellularis bacteria traverse the intestinal lumen and invade the immature epithelial cells lining the intestinal crypts. Infected cells fail to mature normally and continue proliferating, resulting in thickening of the intestinal mucosa with a characteristic corrugated or brain-like appearance. This proliferative tissue lacks normal absorptive function, leading to malabsorption, diarrhea, and reduced feed efficiency. In the acute hemorrhagic form, severe mucosal damage leads to bleeding into the intestinal lumen with development of potentially fatal anemia. The coagulative necrosis and inflammation that develop in chronic cases can progress to fibrosis and permanent intestinal damage in severe or prolonged infections.

Early warning signs of ileitis may be subtle and easily overlooked in commercial swine operations, particularly for the subclinical and early chronic forms of disease. Affected pigs may show slightly reduced appetite and decreased feed intake that becomes apparent when group consumption data is analyzed. Growth rate may decline before other clinical signs become obvious, with affected pigs gradually falling behind their penmates in body weight. Fecal consistency may become slightly softer than normal without progressing to obvious diarrhea in the early stages. Behavioral changes including reduced activity and decreased interest in environmental exploration may precede more obvious clinical signs. These early indicators are frequently missed, allowing disease to progress before intervention occurs.

The clinical presentation of ileitis varies considerably depending on the form of disease present, with three main syndromes recognized. Porcine intestinal adenomatosis, the chronic form, typically affects growing pigs 6 to 20 weeks old and presents with reduced growth rate, mild to moderate diarrhea with pasty to watery consistency, and variable feed intake without severe systemic illness. Proliferative hemorrhagic enteropathy, the acute form, affects older animals including finishing pigs and young breeding stock, presenting with sudden onset of bloody or tarry diarrhea, rapid development of severe anemia, and potential sudden death. Necrotic enteritis and regional ileitis represent chronic complicated forms with more severe intestinal damage and systemic illness. Subclinical infection causes growth reduction and impaired feed efficiency without obvious clinical signs.

Behavioral changes associated with ileitis reflect both intestinal discomfort and systemic effects of infection and nutrient malabsorption. Affected pigs often show reduced competitive behavior at feeders, allowing more aggressive penmates to displace them. Activity levels decline, with affected animals spending more time lying and less time engaged in normal behaviors. Pigs with chronic ileitis may develop a characteristic hunched posture with an arched back suggesting abdominal discomfort. Social interaction decreases as affected animals become more withdrawn. In the acute hemorrhagic form, affected pigs rapidly become weak and lethargic, with minimal response to stimuli as anemia progresses.

Physical examination findings depend on the form and severity of disease but commonly include evidence of poor body condition and intestinal dysfunction. Pigs with chronic ileitis are typically thin and may show poor hair coat quality despite adequate nutrition. Abdominal palpation is generally unremarkable, though intestinal thickening may occasionally be detected in severely affected animals. The acute hemorrhagic form produces dramatic findings including severe pallor of skin and mucous membranes due to blood loss anemia, weakness, increased heart and respiratory rates, and cool extremities indicating compromised circulation. Fecal material may range from soft and pasty in chronic cases to frankly bloody or tar-like in acute hemorrhagic disease.

Symptom progression differs substantially between the chronic and acute forms of ileitis. Chronic porcine intestinal adenomatosis develops gradually over days to weeks, with progressive growth reduction, intermittent diarrhea, and declining body condition. Without treatment, affected animals may eventually recover with development of immunity but will have suffered significant performance losses. The acute hemorrhagic form progresses rapidly, with affected animals transitioning from apparently normal to severely ill within 24 to 48 hours. Massive intestinal hemorrhage produces profound anemia that may prove fatal before diagnosis is possible. Death may occur within 24 to 72 hours of symptom onset in severe cases, sometimes with affected animals found dead without premonitory signs observed.

Emergency symptoms requiring immediate veterinary attention include sudden onset of bloody or black tarry diarrhea, particularly in older pigs or breeding stock that may have the acute hemorrhagic form. Marked pallor of skin and mucous membranes indicates severe anemia requiring urgent assessment. Weakness, collapse, or inability to rise suggests advanced disease with cardiovascular compromise. Multiple sudden deaths in a group of finishing pigs or gilts should prompt immediate investigation. Rapid progression from normal appearance to severe illness over hours indicates an acute process requiring emergency response. Any pig passing frank blood or having extremely dark feces should be considered an emergency, as hemorrhagic ileitis can prove rapidly fatal without intervention.

Clinical examination of pigs with suspected ileitis focuses on assessing signs of enteric disease, growth reduction, and in acute cases, evidence of hemorrhage and anemia. Physical examination findings are often nonspecific in chronic cases, with thin body condition, poor hair coat, and soft feces being consistent with numerous enteric conditions. The acute hemorrhagic form presents more dramatically with severe pallor, weakness, and bloody or tarry feces that raise strong suspicion for this diagnosis in the appropriate age group. Group-level assessment identifies the proportion of animals affected, growth variation within the group, and overall performance metrics suggesting disease impact. Clinical history including age at onset, recent management changes, and vaccination status informs diagnostic probability.

Diagnostic tests for ileitis include several options for detecting Lawsonia intracellularis infection in live animals and confirming diagnosis postmortem. Polymerase chain reaction testing of feces provides sensitive and specific detection of bacterial DNA, with quantitative PCR allowing estimation of shedding levels that may correlate with disease severity. Serological testing using ELISA or immunofluorescence detects antibodies to Lawsonia intracellularis, indicating exposure but not necessarily active disease. Serology is most useful for herd-level screening and monitoring immune status rather than individual animal diagnosis. Histopathology of intestinal biopsies can demonstrate characteristic proliferative lesions, but biopsy collection is impractical in most clinical situations. Necropsy examination with histopathological evaluation of intestinal tissues provides definitive diagnosis in fatal cases.

Differential diagnosis of ileitis must consider other causes of diarrhea, growth reduction, and intestinal hemorrhage in growing pigs. Swine dysentery caused by Brachyspira hyodysenteriae produces large intestinal disease with mucohemorrhagic diarrhea that may resemble ileitis clinically. Salmonellosis can cause enteric disease with systemic illness and variable fecal character. Gastric ulceration produces melena and anemia similar to acute hemorrhagic ileitis but with gastric rather than intestinal lesions. Porcine circovirus-associated disease causes wasting and intestinal pathology that may complicate or mimic ileitis. Dietary factors causing diarrhea and poor growth must be excluded. Hemorrhagic bowel syndrome produces sudden death with intestinal hemorrhage but typically involves the jejunum rather than ileum. Thorough diagnostic evaluation differentiates these conditions.

Herd-level diagnostics provide essential information for understanding ileitis epidemiology and developing control strategies in affected operations. Serological profiling of different age groups reveals infection timing and immune status across the production flow, guiding decisions about vaccination timing. Fecal PCR sampling of groups at different stages identifies when shedding peaks occur. Slaughter surveillance including gross examination and histopathology of intestinal tissues from market pigs provides outcome data on subclinical disease prevalence. Production data analysis comparing growth performance before and after intervention helps quantify disease impact and evaluate control measure effectiveness. Diagnostic submissions should be coordinated with the herd veterinarian to develop a comprehensive picture of ileitis status and guide management decisions.

Emergency treatment of acute hemorrhagic ileitis requires rapid intervention to address life-threatening anemia and ongoing intestinal hemorrhage. Severely affected pigs should be moved carefully to a quiet area with minimal stress, as physical exertion can worsen cardiovascular strain in anemic animals. Parenteral antibiotic administration provides the most reliable drug delivery in acutely ill animals that may not be eating or drinking. Supportive fluid therapy helps maintain circulation though it cannot replace lost red blood cells. Blood transfusion from a healthy donor pig may be considered for extremely valuable animals, though this is rarely practical in commercial settings. Iron supplementation supports red blood cell regeneration during recovery. Despite aggressive treatment, mortality in acute hemorrhagic ileitis often exceeds 50 percent once severe clinical signs develop.

Medical management of ileitis relies on antimicrobial therapy targeting Lawsonia intracellularis, with several antibiotics demonstrating efficacy. Tylosin, tiamulin, lincomycin, and tetracyclines are commonly used, administered orally through water or feed for group treatment or parenterally for individual clinically affected animals. Carbadox has historically been effective but is no longer available in some markets due to regulatory restrictions. Treatment duration typically extends 14 to 21 days to address the intracellular infection adequately. Injectable antibiotics including tylosin and lincomycin are preferred for individual treatment of acutely ill animals. Antimicrobial selection should consider local resistance patterns, though true resistance in Lawsonia intracellularis is difficult to assess due to the organism's inability to grow on standard culture media. Withdrawal times must be observed for all treatments in food animals.

Surgical intervention has no role in treating ileitis, as the diffuse intestinal pathology is not amenable to surgical correction. The thickened intestinal segments characteristic of chronic ileitis cannot be practically resected, and the underlying infection would continue in remaining intestinal tissue. Surgical exploration might occasionally be considered diagnostically in valuable animals with undiagnosed abdominal disease, but this is rarely undertaken in swine practice. Management of ileitis remains firmly in the realm of medical therapy combined with supportive care and risk factor modification.

Supportive care measures complement antimicrobial therapy and improve outcomes in pigs recovering from ileitis. Nutritional support through provision of highly digestible diets helps compensate for reduced intestinal absorptive capacity. Electrolyte supplementation addresses losses from diarrhea. Adequate water access is essential for hydration and facilitates oral medication delivery when water-based treatment is used. Iron supplementation supports recovery from anemia, particularly in pigs recovering from the hemorrhagic form. Environmental optimization with appropriate temperature, ventilation, and reduced stocking density minimizes stress during recovery. Probiotic supplementation may aid restoration of normal intestinal microbiota following antibiotic treatment.

Herd treatment protocols address both clinically affected individuals and subclinically infected penmates in group housing situations. Water medication provides relatively rapid drug delivery to groups of pigs and is often preferred for acute outbreak situations. Feed medication allows strategic treatment of groups at high-risk periods, such as during the post-weaning phase when clinical disease commonly develops. Pulse dosing strategies using repeated shorter treatment courses may be more effective and economical than continuous medication for chronic herd problems. Treatment timing should target the period before expected clinical disease onset based on understanding of infection dynamics in the specific herd. Combination with vaccination may provide complementary benefits, with treatment reducing disease pressure while immunity develops.

Treatment decisions in ileitis management must balance animal welfare, economic considerations, and antimicrobial stewardship concerns. Individual treatment of acutely affected pigs is appropriate when prognosis is reasonable and treatment costs are justified by animal value. The decision to treat groups prophylactically or metaphylactically involves weighing expected disease losses against medication costs and concerns about antimicrobial use in food animals. Severely affected animals with poor prognosis may be humanely euthanized rather than subjected to prolonged unsuccessful treatment. Chronic poor-doing pigs that fail to respond to treatment may be culled from the herd. These decisions should be made in consultation with the herd veterinarian, considering regulatory requirements, market specifications regarding antibiotic use, and overall herd health management goals.

Recovery timeline for ileitis varies depending on disease severity, form of presentation, and timeliness of treatment initiation. Pigs with uncomplicated chronic ileitis typically show improvement within 3 to 5 days of starting antimicrobial therapy, with resolution of diarrhea and improved appetite. Full recovery of intestinal function and return to normal growth rates may require 2 to 4 weeks as damaged mucosa heals and regenerates. Animals recovering from acute hemorrhagic ileitis face longer recovery periods due to the need for red blood cell regeneration, which may require 4 to 8 weeks for complete restoration of normal hematological parameters. Severely affected animals may never fully recover lost growth performance and may remain permanently stunted compared to unaffected contemporaries.

Post-treatment care and monitoring are essential components of successful recovery management. Treated animals should be observed for resolution of clinical signs including normalization of fecal consistency, return of appetite, and improved activity levels. Weight gain resumption indicates successful treatment response and restoration of intestinal absorptive function. Monitoring for treatment failure or relapse helps identify animals requiring extended therapy or alternative antimicrobial selection. Group performance metrics including average daily gain and feed efficiency assess overall treatment impact. Pigs recovering from hemorrhagic ileitis require monitoring of mucous membrane color and general strength as indicators of anemia resolution.

Prognostic factors influencing recovery outcomes include the form of disease present, severity at diagnosis, timing of treatment initiation, and presence of complicating factors. Chronic ileitis diagnosed early and treated promptly carries a good prognosis for survival and reasonable prognosis for performance recovery. Acute hemorrhagic ileitis carries guarded prognosis, with mortality often exceeding 50 percent in severely affected animals despite treatment. Animals diagnosed and treated before severe anemia develops have better outcomes. Concurrent infections with other pathogens, underlying immunosuppression from porcine circovirus or other causes, and poor nutritional status worsen prognosis. Individual animal factors including age, body condition, and immune status influence recovery potential.

Return to production considerations apply to recovering animals in both market and breeding contexts. Growing pigs recovering from ileitis often experience growth setbacks that may persist, resulting in lighter weights at standard marketing ages or requiring extended finishing periods. Calculations of continued feeding costs versus expected market value help determine whether recovery or early marketing is economically optimal for affected individuals. Breeding stock that develop ileitis, particularly gilts that may have the acute hemorrhagic form, can potentially return to normal reproductive function after recovery but should be allowed adequate convalescence before breeding. Performance of recovered animals should be monitored, as some may experience chronic intestinal damage that limits their future productivity.

Vaccination against Lawsonia intracellularis represents a cornerstone of ileitis prevention in commercial swine operations, with both oral and injectable vaccines commercially available. Oral live attenuated vaccines are administered in drinking water to pigs typically around 3 weeks of age, providing mucosal immunity that helps prevent intestinal colonization. Injectable killed bacterin vaccines stimulate systemic immunity and are given by intramuscular injection, typically requiring two doses several weeks apart. Vaccine selection depends on farm-specific factors including production flow, labor availability, and disease timing. Protection develops over 2 to 3 weeks following vaccination, so timing must account for expected infection exposure. Vaccination reduces clinical disease severity and improves growth performance but may not prevent infection entirely in endemic herds.

Biosecurity measures help prevent introduction of Lawsonia intracellularis to naive herds and reduce transmission within infected operations. All-in-all-out production by room or building, with thorough cleaning and disinfection between groups, reduces bacterial carryover and breaks transmission cycles. Isolation and testing of incoming breeding stock before introduction to the main herd helps identify carriers. Rodent and pest control eliminates potential reservoirs, as mice have been shown capable of carrying and shedding Lawsonia intracellularis. Boot changes and equipment sanitation between buildings prevent mechanical transmission by workers. Traffic patterns that move from younger to older animals reduce exposure of susceptible groups.

Nutritional strategies may influence ileitis susceptibility and disease expression, though dietary effects are less well-established than for some other swine diseases. Highly digestible diets that minimize undigested material reaching the hindgut may reduce substrate for bacterial growth. Feed additives including organic acids, zinc oxide, and certain probiotics have been evaluated for potential benefits in reducing enteric disease including ileitis. Fiber source and level may influence intestinal microbiota composition and disease susceptibility. Consistency in diet formulation and gradual transitions during feed changes reduce intestinal stress that may predispose to clinical disease expression.

Management practices during high-risk periods help reduce ileitis incidence and severity. The post-weaning period represents a critical time when maternal immunity wanes and infection commonly occurs, warranting enhanced attention to environmental conditions, nutrition, and potentially strategic medication or vaccination. Minimizing mixing of pigs from different sources reduces introduction of new Lawsonia strains and prevents transmission events associated with social stress. Adequate space allocation and comfortable environmental conditions reduce stress that may compromise immunity. Attention to water system cleanliness ensures that water-based medications or vaccines are delivered in clean water without biofilm contamination.

Monitoring and surveillance programs enable early detection of ileitis problems and assessment of prevention program effectiveness. Serological profiling at different production stages reveals infection timing and population immunity status. Fecal PCR testing identifies active shedding and can monitor effects of interventions. Slaughter surveillance provides data on subclinical intestinal lesions in marketed pigs. Production data analysis comparing vaccinated versus unvaccinated groups or periods before and after intervention implementation quantifies program value. Regular veterinary review of surveillance data and disease occurrence enables timely adjustment of prevention protocols to maintain effective control.

Daily management and monitoring practices support early detection of ileitis and optimize conditions for pig health and performance. Observation rounds should include assessment of fecal consistency within pens, with increased soft or watery feces prompting further investigation. Feed consumption monitoring identifies decreases that may indicate emerging health problems. Individual pig observation, while challenging in large groups, should note animals with poor body condition, diarrhea staining, or behavioral indicators of illness. Growth variation within groups, visible as size differences between penmates, may indicate subclinical disease affecting a proportion of animals. Record keeping of observations, treatments, and outcomes enables trend analysis and informed management decisions.

Housing and environmental management directly impact ileitis risk and expression through effects on transmission, stress, and immune function. All-in-all-out management with thorough cleaning between groups reduces environmental bacterial load and prevents carryover to incoming susceptible pigs. Cleaning protocols should include removal of all organic material followed by disinfection with products effective against gram-negative bacteria and adequate contact time. Drying facilities before restocking reduces bacterial survival. Temperature control maintains comfort and reduces stress, while adequate ventilation provides fresh air without drafts. Stocking density appropriate for pig size and facility design minimizes stress and reduces contact transmission opportunities.

Comprehensive herd health programs integrate ileitis management with control of other diseases sharing common risk factors and management approaches. Vaccination schedules should include Lawsonia intracellularis immunization at appropriate timing based on farm-specific infection dynamics. Other enteric disease vaccinations and interventions complement ileitis control. Antimicrobial stewardship programs ensure responsible medication use while maintaining effective disease management. Nutritional programs developed in consultation with swine nutritionists optimize gut health across production phases. Genetic considerations may include selection for general disease resistance and robustness. Regular veterinary consultation provides professional oversight and enables program refinement based on disease occurrence and production data.

Record keeping and monitoring systems provide data essential for managing ileitis and evaluating program effectiveness over time. Treatment records document medications used, dosages, treatment durations, and withdrawal compliance. Mortality records by age group and diagnosed cause identify ileitis-related deaths and enable trend analysis. Vaccination records confirm protocol compliance and enable correlation with disease outcomes. Production data including growth rates, feed efficiency, and marketing weights quantify disease impact and intervention benefits. Diagnostic laboratory submissions and results should be maintained for reference and surveillance data accumulation. Regular data review identifies emerging problems and opportunities for management improvement.

Economic considerations guide resource allocation for ileitis prevention and treatment programs. Vaccination costs must be weighed against expected benefits from reduced mortality, improved growth performance, and decreased treatment expenses. Feed medication costs and potential marketing restrictions associated with antibiotic use factor into treatment program decisions. Performance losses from subclinical ileitis, though harder to quantify, often exceed obvious clinical losses and justify prevention investment. Return on investment analysis for different intervention options helps prioritize spending. The veterinarian and nutritionist can assist with economic modeling to support informed decision-making. Ongoing monitoring confirms that prevention investments continue to provide value as disease pressure and market conditions change.

No specific breed or genetic line of pigs has been definitively identified as having markedly increased susceptibility to ileitis compared to others, though individual variation in susceptibility clearly exists. The near-ubiquitous presence of Lawsonia intracellularis infection across global swine populations suggests that all common commercial breeds and crossbreeds are susceptible to infection. Variation in disease expression likely relates more to management factors, immune status, and concurrent health challenges than to breed-specific susceptibility. Some evidence suggests that individual animals vary in their immune responses to Lawsonia intracellularis, which could have a genetic basis, but this has not been characterized to the degree seen with certain other swine diseases where specific genetic susceptibility factors have been identified.

Production type and management system appear to influence ileitis occurrence and clinical expression more than genetic background. Intensive finishing operations with large group sizes, high animal density, and continuous production flow typically experience more consistent ileitis challenges than extensive or pasture-based systems with lower infection pressure. Fast-growing terminal crosses selected for maximum lean growth efficiency may experience more performance impact from subclinical ileitis than slower-growing heritage or maternal lines, though direct comparisons are limited. Young breeding stock, particularly gilts sourced from external multiplication farms, may be particularly susceptible to acute hemorrhagic ileitis when introduced to endemic herds with unfamiliar Lawsonia strains.

Genetic selection for ileitis resistance is not currently a major focus of commercial breeding programs, though selection for general disease resistance and immune competence may provide indirect benefits. The traits selected in maternal versus terminal lines differ, potentially creating variation in disease response between these genetic types. As genomic tools become more sophisticated and associations between genetic markers and disease susceptibility are identified, selection for ileitis resistance may become feasible. Currently, management of ileitis in commercial operations relies on vaccination, strategic medication, and environmental management rather than genetic approaches. Producers experiencing severe ileitis problems should focus on these controllable factors rather than seeking genetic solutions that are not yet available.

Several enteric and systemic conditions commonly co-occur with ileitis or share similar clinical presentations requiring differentiation. Porcine circovirus type 2 infection is frequently present alongside Lawsonia intracellularis, with circovirus-associated immunosuppression potentially worsening ileitis severity and clinical expression. Swine dysentery caused by Brachyspira hyodysenteriae affects the large intestine and may occur in the same populations as ileitis, sometimes in the same individuals. Salmonellosis produces enteric and systemic disease that may coexist with or be confused for ileitis. Rotavirus and transmissible gastroenteritis virus infections may predispose pigs to secondary bacterial enteritis including ileitis. Mixed infections with multiple enteric pathogens are common in commercial swine and complicate both diagnosis and management.

Differential diagnosis of ileitis must consider conditions producing similar clinical signs of diarrhea, poor growth, and intestinal hemorrhage. Swine dysentery presents with large intestinal inflammation and mucohemorrhagic diarrhea distinct from the small intestinal pathology of ileitis on necropsy, though clinical differentiation may be difficult. Gastric ulceration produces anemia and melena that closely resembles acute hemorrhagic ileitis, requiring careful postmortem examination to differentiate stomach versus intestinal origin of hemorrhage. Hemorrhagic bowel syndrome causes acute death with intestinal hemorrhage primarily in the jejunum. Salmonella enteritis may produce bloody diarrhea with systemic illness. Dietary factors causing diarrhea and poor performance in growing pigs must be excluded. Accurate diagnosis requires appropriate diagnostic testing rather than reliance on clinical signs alone.

Complications of ileitis extend the condition's impact beyond the primary intestinal infection. Chronic intestinal damage may result in permanent fibrosis and stricture formation that causes ongoing malabsorption and poor performance. Secondary bacterial infections may develop in damaged intestinal tissue, complicating recovery and prolonging illness. Iron deficiency anemia following hemorrhagic ileitis may persist if dietary iron is insufficient to support red blood cell regeneration. Rectal stricture is an occasional complication that causes progressive constipation and may require euthanasia. Chronic poor-doing pigs that survive initial illness may never achieve adequate performance and serve as reservoirs for ongoing transmission to susceptible penmates. Recognition of these potential complications informs prognosis and management decisions for affected individuals and herds.